|
|
|
| NuAge #5 Kali Mur (Kali Muriaticum) |
| by Hylands
Homeopathic Tissue Remedy |
|
Size :
125 Tabs
SKU # :
HY0194
Prod. ID:
25329
UPC Code:
354973522480
Retail Price:
$5.28
Discount:
26%
Our Price:
$3.93
|
|
|
|
|
 |
|
|
|
|
 |
 |
|
|
 |
 |
 |
Description of NuAge #5 Kali Mur (Kali Muriaticum)
|
|
KALI MUR is the remedy for relief of symptoms of sluggish conditions and symptoms affecting the mucous membranes with thick, white discharges: coughs, colds, sore throats and catarrh. This tissue salt is useful as a first aid Favorable Effects for burns. Symptoms may be worse with motion and after eating fatty or rich foods.
KALI MUR is specifically useful for the symptoms of: COUGHS- children's coughs, with white coated tongue and white phlegm can be relieved with the tissue remedy KALI MUR. Eyes- eye irritation with whitish discharge. SKIN Symptom (Subject feeling)S are a large and important group which influence the general health. KALI MUR is an effective tissue remedy relief of symptoms of the second stages of inflammatory conditions. Thick, white eruptions accompanied by a white coated tongue are indications for KALI MUR.
|
|
 |
 |
 |
Ingredients of NuAge #5 Kali Mur (Kali Muriaticum)
|
|
 |
|
Kali Muriaticum 6X HPUS in a base of Lactose NF.
|
|
 |
 |
 |
Suggested Use for NuAge #5 Kali Mur (Kali Muriaticum)
|
|
|
Adults & children over 6 years of age: 4 tablets.
Children (ages 1 to 6): 2 tablets.
Dissolve under tongue 3 times a day. Use more frequently (every 15 mins. for 8 doses) with acute conditions.
|
|
 |
 |
 |
| Additional
Information for
NuAge #5 Kali Mur (Kali Muriaticum)
|
|
|
For the temporary symptomatic relief of the symptoms of Coughs, Eye Irritation, Skin Subjective feelings.
|
|
 |
 |
 |
Warning for NuAge #5 Kali Mur (Kali Muriaticum)
|
|
|
Do not use if imprinted tamper band is broken or missing. As with any drug, if you are pregnant or nursing a baby, seek the advice of a licensed health care professional before using this product. Keep this and all medications out of the reach of children.
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|